Milestone Pharmaceuticals Inc expected to post a loss of 26 cents a share - Earnings Preview

Milestone Pharmaceuticals

07/05/2024 16:12

* Milestone Pharmaceuticals Inc  MIST.OQ   MIST.O  is
expected
to show a fall in quarterly revenue when it reports  results on
May 9 (estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Milestone
Pharmaceuticals Inc
is for a loss of 26 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 9.4%
in the last three months. ​
    * Wall Street's median 12-month price target for Milestone
Pharmaceuticals Inc is $7.00​, above​ its last closing price
of $1.74. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.30       -0.31      -0.32     Missed  -2.4
 Sep. 30 2023  -0.38       -0.38      -0.35     Beat    8.4
 Jun. 30 2023  -0.38       -0.39      -0.37     Beat    4.1​
 Jan. 1 0001   -0.40       -0.40      -0.35     Beat    12.1
 ​​Dec.                    -0.33      -0.31     Beat    7.5
 31 2022                                                
 Sep. 30 2022  -0.40       -0.41      -0.34     Beat    16.7​
 Jan. 1 0001   -0.34       -0.36      -0.39     Missed  -8.3
 Mar. 31 2022  -0.38       -0.39      -0.33     Beat    15.4
 This summary was machine generated May 7 at 15:11 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)